Cigna Healthcare has removed prior authorization requirements for a wide range of tests, treatments and medical equipment, but not prescription drugs.
Cigna Healthcare has removed 600 additional codes for medical services from prior authorization requirements. Since 2020, the health plan has removed more than 1,100 medical services from prior authorization requirements.
In the latest effort, the services being removed from prior authorization requirements include a wide range of tests, treatments and medical equipment, including more than 100 surgical codes, nearly 200 genetic testing codes, durable medical equipment, and orthoses and prosthetics, a Cigna spokesperson said. But no prescription medications have been removed from prior authorizations.
David Brailer, M.D.
“We’ve listened attentively to our clinician partners and are deliberately making these changes as a result. We will continue to hold ourselves accountable for this important work and look forward to building on this momentum in the future,” David Brailer, M.D., executive vice president and chief health officer, The Cigna Group, said in a press release.
With this update, prior authorization now applies to less than 4% of medical services for most Cigna Healthcare customers. Cigna Healthcare will also remove prior authorization for nearly 500 codes for Medicare Advantage plans later this year.
Cigna’s move follows a similar one earlier this month from United Healthcare, which will remove almost 20% of prior authorization requirements. Beginning Sept. 1, 2023, some codes will be removed from UnitedHealthcare Medicare Advantage, UnitedHealthcare commercial, UnitedHealthcare Oxford and UnitedHealthcare Individual Exchange plans. Other codes will be removed Nov. 1, 2023. Changes for UnitedHealthcare Community Plan will take place on Nov. 1, 2023, according to the company.
United Healthcare also said that in 2024, it will implement a national Gold Card program for provider groups that meet eligibility requirements, which will allow for a more simple process for prior authorizations.
Prior authorization has come under fire by doctor groups and members in Congress. The American Medical Association says that prior authorization is overused and places a burden on doctors. Physicians and their staff spend almost two days a week completing prior authorizations, according to the AMA.
In July, the House Ways and Means Committee conducted a mark up of a bill that would address prior authorization in Medicare. The bipartisan bill would establish an electronic program for prior authorizations and expand patient protections. The Improving Seniors’ Timely Access to Care Act unanimously passed the House last Congress and was cosponsored by a majority of members in the Senate and House of Representatives.
“I commend the efforts of the House Ways and Means Committee for investing in our legislation along with other patient-centered reforms in this cost-effective package. My bipartisan, bicameral co-leads and I will continue to work towards advancing the Improving Seniors’ Timely Access to Care Act to the finish line in Congress and through federal health agencies,” U.S. Senator Roger Marshall, M.D. (R-Kan.) said in a press release.
Marshall and other senators recently sent letters to the Centers for Medicare & Medicaid Services (CMS) urging the agency to quickly finalize a set of proposed rules for prior authorization with Medicare Advantage.
These moves were taken after the Officer of Inspector General of the Department of Health and Human Services issued a report in April 2022. They found that 13% of prior authorization denials by Medicare Advantage plans were for benefits were covered under Medicare, such as MRIs and inpatient rehabilitation. Plans tended to use clinical criteria that are not contained in Medicare coverage rules,
Additionally, the OIG released in July 2023 a report about prior authorization denials in Medicaid Managed Care. They found that Medicaid managed care organization denied one out of every eight requests for the prior authorization of services in 2019. And 12 plans had prior authorization denial rates greater than 25%, which the OIG said was twice the overall rate.
FDA Authorizes Novavax COVID-19 Vaccine
October 4th 2023It differs from the Pfizer and Moderna vaccine. Instead of using mRNA, the Novavax vaccines consists of proteins found in the spikes of the COVID-19 vaccine combined with an adjuvant made from the bark of a tree that grows in Chile.
Read More
Mostafa Kamal Talks Prime Therapeutics, Magellan Rx Integration, the Organization's Trajectory, More
September 13th 2023Managed Healthcare Executive's Managing Editor Peter Wehrwein, and Editor Briana Contreras, had a discussion in July with Mostafa Kamal, president and CEO of Prime Therapeutics, an organization in which Kamal acquired this position that same month.
Listen
Medicare’s Drug Negotiation Could Lead to Greater Access — or More Utilization Management
October 3rd 2023Even though the Inflation Reduction Act will require plans to justify formulary placement of negotiated drugs, payers have more of an incentive to steer patients to lower-cost alternatives.
Read More
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
Reduced Mortality Associated to Vitiligo
October 2nd 2023In a population-based cohort study, researchers explored the mortality of vitiligo as there is limited information about risks of mortality among these patients. The researchers investigated all-cause and cause-specific mortality of patients with vitiligo compared with controls without vitiligo using a nationwide database.
Read More
2 Clarke Drive
Cranbury, NJ 08512